Cytokine balance in the lungs of patients with acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 10 I, 2001, Pages 1896-1903

  Park, William Y ^b   Goodman, Richard B ^b   Steinberg, Kenneth P ^b   Ruzinski, John T ^b   Radella II, Frank ^b   Park, David R ^b   Pugin, Jerome ^b   Skerrett, Shawn J ^b   Hudson, Leonard D ^b   Martin, Thomas R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Acute respiratory distress syndrome; Cytokine receptors; Cytokines; IL 1; TNF

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; BIOACCUMULATION; BIOASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNOASSAY; INFLAMMATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

EID: 0035891593     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.10.2104013     Document Type: Article

References (47)

1. The acute respiratory distress syndrome
2. Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome
3. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema
4. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis
5. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome
6. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome
7. Clinical trials for severe sepsis. Past failures, and future hopes
8. Biological markers of acute lung injury: Prognostic and pathogenetic significance
9. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses
10. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome
11. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation
12. Circulating serum levels of IL-1ira in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment
13. Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis
14. Increased IL-1 receptor antagonist (IL-1ra) production and decreased IL-1 beta/IL-1ra ratio in mononuclear cells from rheumatoid arthritis patients
15. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10
16. Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis
17. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators
18. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome
19. Neutrophil apoptosis in the acute respiratory distress syndrome
20. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS
21. Report of the American-European Consensus Conference on acute respiratory distress syndrome: Definitions, mechanisms, relevant outcomes, and clinical trial coordination
22. Effects of endotoxin in the lungs of neonatal rats: Age-dependent impairment of the inflammatory response
23. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor
24. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1
25. Cytokines in normal and abnormal parturition: Elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection
26. A growth factor for B cell hybridomas produced by human monocytes
27. Soluble receptors in human disease
28. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties
29. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor
30. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4
31. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase
32. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
33. Imbalance of the interleukin 1 system in colonic mucosa - Association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2
34. Macrophage deactivation by interleukin 10
35. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor
36. Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes
37. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis
38. Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome
39. Interleukin-1
40. Characterization and biologic activities of recombinant rat soluble interleukin-6 receptor
41. Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors
42. Normal responses to injury prevent systemic inflammation and can be immunosuppressive
43. Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome
44. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein
45. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes
46. Interleukin-6 autoantibodies: Possible biological and clinical significance
47. Anti-interleukin-6 autoantibodies in plasma are associated with an increased frequency of infections and increased mortality of patients with alcoholic cirrhosis